Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Fibrocell Science, Inc. (NASDAQ: FCSC) on Behalf of Fibrocell Shareholders and Encourages Fibrocell Investors to Contact the Firm

Read MORE

NEW YORK, Sept. 17, 2019 /PRNewswire/ — Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Fibrocell Science, Inc. (NASDAQ: FCSC) on behalf of Fibrocell shareholders concerning the proposed merger with Castle Creek Pharmaceutical Holdings….